Display options
Cite
Asmis T, Balaa F, Scully L, et al. Diagnosis and management of hepatocellular carcinoma: results of a consensus meeting of The Ottawa Hospital Cancer Centre. Curr Oncol. 2010;17(2):6-12doi: 10.3747/co.v17i2.555.
Asmis, T., Balaa, F., Scully, L., Papadatos, D., Marginean, C., Fasih, N., Shaw-Stiffel, T., & Goel, R. (2010). Diagnosis and management of hepatocellular carcinoma: results of a consensus meeting of The Ottawa Hospital Cancer Centre. Current oncology (Toronto, Ont.), 17(2), 6-12. https://doi.org/10.3747/co.v17i2.555
Asmis, T, et al. "Diagnosis and management of hepatocellular carcinoma: results of a consensus meeting of The Ottawa Hospital Cancer Centre." Current oncology (Toronto, Ont.) vol. 17,2 (2010): 6-12. doi: https://doi.org/10.3747/co.v17i2.555
Asmis T, Balaa F, Scully L, Papadatos D, Marginean C, Fasih N, Shaw-Stiffel T, Goel R. Diagnosis and management of hepatocellular carcinoma: results of a consensus meeting of The Ottawa Hospital Cancer Centre. Curr Oncol. 2010 Apr;17(2):6-12. doi: 10.3747/co.v17i2.555. PMID: 20404972; PMCID: PMC2854641.
Copy Download .nbib Format: NLM
Share it on

Curr Oncol. 2010 Apr;17(2):6-12. doi: 10.3747/co.v17i2.555.

Diagnosis and management of hepatocellular carcinoma: results of a consensus meeting of The Ottawa Hospital Cancer Centre.

Current oncology (Toronto, Ont.)

T Asmis, F Balaa, L Scully, D Papadatos, C Marginean, N Fasih, T Shaw-Stiffel, R Goel

Affiliations

  1. The Ottawa Hospital Cancer Centre, Ottawa, Ontario. [email protected]

PMID: 20404972 PMCID: PMC2854641 DOI: 10.3747/co.v17i2.555

Abstract

Hepatocellular carcinoma (HCC) is an uncommon tumour, but its incidence is increasing in Canada and elsewhere. Currently, there are no Canadian recommendations for diagnosis and treatment of hcc, and possible options may have regional limitations. A consensus symposium was held in the Ottawa region to consider current diagnostic and management options for hcc. These recommendations were developed: Diagnosis-with adequate imaging, a biopsy is not required pre-surgery, but is required before the start of systemic therapy; lesions smaller than 1 cm should be followed and not biopsied; repeat biopsies should be core tissue biopsies; magnetic resonance imaging is preferred, but triphasic computed tomography imaging can be useful. Resection-recommended for localized HCC. Radiofrequency ablation-recommended for unresectable or non-transplantable HCC; should not be performed in the presence of ascites. Trans-arterial chemoembolization (TACE)-doxorubicin with lipiodol is the agent of choice; trans-catheter embolization is an alternative for patients if TACE is not tolerated or is contraindicated. Medical management-first-line sorafenib should be considered the standard of care. Transplantation-suitable patients meeting Milan criteria should be assessed for a graft regardless of other treatments offered. The authors feel that the recommendations from this consensus symposium may be of interest to other regions in Canada.

Keywords: hcc; hepatoma; regional consensus guideline; treatment

References

  1. N Engl J Med. 2008 Jul 24;359(4):378-90 - PubMed
  2. J Exp Clin Cancer Res. 2003 Dec;22(4 Suppl):233-41 - PubMed
  3. Cancer Res. 2006 Dec 15;66(24):11851-8 - PubMed
  4. Am J Gastroenterol. 2006 Mar;101(3):513-23 - PubMed
  5. Cancer. 1998 Mar 15;82(6):1028-36 - PubMed
  6. Ann Surg. 2006 Mar;243(3):321-8 - PubMed
  7. Gut. 2005 Aug;54(8):1151-6 - PubMed
  8. Am J Clin Oncol. 2003 Aug;26(4):344-9 - PubMed
  9. Gastroenterology. 2004 Nov;127(5 Suppl 1):S27-34 - PubMed
  10. Lancet. 2003 Dec 6;362(9399):1907-17 - PubMed
  11. J Natl Cancer Inst. 2005 Oct 19;97(20):1532-8 - PubMed
  12. Nat Rev Drug Discov. 2006 Oct;5(10):835-44 - PubMed
  13. J Hepatol. 2006 Apr;44(4):723-31 - PubMed
  14. Cardiovasc Intervent Radiol. 2007 Jan-Feb;30(1):6-25 - PubMed
  15. Lancet Oncol. 2009 Jan;10(1):25-34 - PubMed
  16. Clin Gastroenterol Hepatol. 2008 Apr;6(4):459-64 - PubMed
  17. Semin Liver Dis. 2005;25(2):181-200 - PubMed
  18. Surg Technol Int. 2004;12:145-51 - PubMed
  19. Eur J Cancer. 2008 Mar;44(4):528-38 - PubMed
  20. Hepatology. 2005 Apr;41(4):707-16 - PubMed
  21. Hepatogastroenterology. 2001 Jan-Feb;48(37):20-4 - PubMed
  22. Am J Surg. 2002 Mar;183(3):309-16 - PubMed
  23. J Hepatobiliary Pancreat Surg. 2008;15(4):410-6 - PubMed
  24. World J Surg. 2005 Feb;29(2):124-30 - PubMed
  25. Hepatology. 2003 Feb;37(2):429-42 - PubMed
  26. J Clin Gastroenterol. 2002 Sep;35(3):266-9 - PubMed
  27. Ann Surg. 2003 Apr;237(4):536-43 - PubMed
  28. Gastroenterology. 2002 May;122(6):1609-19 - PubMed
  29. Arch Surg. 1999 Oct;134(10):1124-30 - PubMed
  30. J Hepatol. 2004 Jan;40(1):124-31 - PubMed
  31. AJR Am J Roentgenol. 2002 Jul;179(1):75-80 - PubMed
  32. Tumori. 2007 May-Jun;93(3):264-8 - PubMed
  33. Gut. 2005 Apr;54(4):533-9 - PubMed
  34. World J Surg Oncol. 2005 May 20;3:27 - PubMed
  35. Mod Pathol. 2008 May;21(5):626-31 - PubMed
  36. Hepatol Res. 2007 Sep;37 Suppl 2:S88-94 - PubMed
  37. N Engl J Med. 1996 Mar 14;334(11):693-9 - PubMed
  38. Radiology. 2002 Jul;224(1):47-54 - PubMed
  39. Drugs. 2008;68(2):251-8 - PubMed
  40. CA Cancer J Clin. 2005 Mar-Apr;55(2):74-108 - PubMed
  41. Am J Gastroenterol. 2003 Mar;98(3):679-90 - PubMed
  42. Health Technol Assess. 2007 Sep;11(34):1-206 - PubMed
  43. Clin Liver Dis. 2005 May;9(2):191-211, v - PubMed
  44. Expert Rev Anticancer Ther. 2008 Oct;8(10):1643-50 - PubMed
  45. J Am Coll Surg. 2008 Jul;207(1):20-9 - PubMed
  46. Proc (Bayl Univ Med Cent). 2008 Jul;21(3):266-80 - PubMed
  47. J Gastroenterol Hepatol. 2007 Feb;22(2):191-6 - PubMed
  48. HPB (Oxford). 2005;7(1):35-41 - PubMed
  49. Hepatology. 2008 Jan;47(1):82-9 - PubMed
  50. Ann Surg. 2001 Jul;234(1):71-8 - PubMed

Publication Types